Yinma Jiedu granules combined with antibacterial drugs for patients with community-acquired pneumonia: protocol for a multicenter, randomized, double-blind, placebo-parallel controlled clinical trial
BackgroundCommunity-acquired pneumonia (CAP) is a severe respiratory infection that can lead to a range of health issues. Yinma Jiedu (YMJD) granules, a representative classic traditional Chinese patent medicine, are widely used in China, yet high-quality evidence regarding their efficacy in allevia...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2025-09-01
|
| Col·lecció: | Frontiers in Medicine |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1612945/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
